MedPath

Evaluation of the efficacy of conditioned medium derived from human umbilical cord Wharton jelly mesenchymal stem cells in the treatment of alopecia areata

Phase 1
Conditions
alopecia areata.
Alopecia areata, unspecified
L63.9
Registration Number
IRCT20200127046282N10
Lead Sponsor
Skin and Stem Cell Research Center, Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
28
Inclusion Criteria

Men and women with alopecia areata
Age 18 years and older and less than 50 years
Complete patient consent to participate in the project

Exclusion Criteria

Platelet disorders
Thrombocytopenia
Patients receiving anticoagulants
Patients with malignancy
Receiving chemotherapy during the last 5 years
Patients with sepsis
Being a smoker
Pregnancy
Active wound or infection at the treatment site
Do not receive any topical or systemic medication in the last 3 months
Women with hyperprolactinemia
Women with hormonal disorders or polycystic ovaries

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath